BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Arthur Klausner to speak at "NC Early-Stage Breakfast" in Raleigh, NC.
News | 11. 14. 2007
